The American College of Radiology (ACR) strongly supports the bicameral, bipartisan legislation to replace the sustainable growth rate (SGR) payment formula. The organization particularly applauds inclusion of several ACR backed provisions that raise quality of care, make care more efficient and increase transparency in physician payment policy.  



Doctors at Henry Ford Hospital in Detroit used an Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device to repair a mitral valve that was narrowed with calcium buildup. William O'Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, estimates this new technique could help thousands of patients a year in the United States.

Transcatheter Technologies GmbH, a medical device company, is developing a third-generation transcatheter aortic valve implantation (TAVI) system, Trinity. An independent laboratory completed advanced wear testing (AWT) of the company’s Trinity valve prosthesis. AWT of the Trinity heart valve has completed 600 million cycles, or an estimated 15 years of durability testing.


The topic of radiation safety and radiation dose monitoring has moved from state-specific regulations to a national trend with The Joint Commission’s (TJCs) recent announcement of their “New and Revised Diagnostic Imaging Standards.” The call for dose management and tracking has graduated from being advised to being mandated – from both a legal perspective and from within the world of healthcare’s patient safety foundation. The question that many organizations find themselves asking is “Where does this leave me?” and “Are we prepared for compliance?”


To address the needs of physicians who treat patients with valvular heart disease, Esaote North America established a sales force to bring 3mensio Structural Heart software for cardiovascular planning solutions.

Boston Scientific launched in the United States the OffRoad Re-Entry Catheter System to treat complete arterial blockages in the major arteries of the legs. Chronic total occlusions (CTOs), are associated with advanced peripheral artery disease (PAD).  

New electrophysiology (EP) ablation mapping/navigation systems recently entered the U.S. market, each offering technology the vendors say will speed procedure time and improve procedural accuracy.


Ziehm Imaging received U.S. Food and Drug Administration (FDA) clearance to market its new generation Ziehm Vision RFD C-arm for pediatric and other interventional operating room procedures. The Ziehm Vision RFD C-arm offers fully motorized movement on four axes to maximize image quality while minimizing procedural dose. It was cleared for a range of image procedures including specific intended uses in pediatric imaging.

The first U.S. implant was announced for St. Jude Medical’s LEADLESS II pivotal trial, designed to evaluate the Nanostim leadless pacemaker for U.S. Food and Drug Administration (FDA) approval. The world’s first retrievable, non-surgical pacemaker was implanted at The Mount Sinai Hospital in New York City by Vivek Reddy, M.D.


Subscribe Now